Modified risk stratification grouping using standard clinical and biopsy information for patients undergoing radical prostatectomy: Results from SEARCH

ConclusionsPatients classified as VHR have markedly increased rates of PSA relapse, DM, and PCSM in comparison to SHR patients, whereas UIR and SHR patients have similar prognosis. Novel therapeutic strategies are needed for patients with VHR, likely involving multimodality therapy.

Source: The Prostate - October 10, 2017 Category: Urology & Nephrology Authors: Zachary S. Zumsteg, Zinan Chen, Lauren E. Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Daniel E. Spratt, Howard M. Sandler, Stephen J. Freedland Tags: ORIGINAL ARTICLE Source Type: research